Female Reproductive System and Ovarian Cycle

Detailed Notes

25.1 Overview of the Female Reproductive System

The female reproductive system is organized around the paired ovaries (the female gonads), the uterine tubes (oviducts/fallopian tubes) that capture and transport oocytes, the uterus where a fertilized embryo implants and develops, the vagina serving as the birth canal and copulatory organ, and the external genitalia (vulva). The system has dual functions: producing haploid female gametes (oocytes) through oogenesis, and supporting the development of an embryo/fetus during pregnancy. The ovaries also serve as endocrine organs, secreting estrogen, progesterone, and inhibin. The mammary glands, though not strictly reproductive organs, are hormonally linked and are considered accessory organs of the female reproductive system — they produce milk under the influence of prolactin and oxytocin after childbirth.

25.2 The Ovaries

25.2.1 Location and Supporting Ligaments

The ovaries are almond-shaped organs, approximately 3 cm long, located in the pelvic cavity on either side of the uterus. They are held in position by three key ligamentous structures:

1. Broad ligament — a large peritoneal fold that drapes over the uterus and extends to the lateral pelvic walls. It contains the uterine tubes within its superior margin and the ovaries attached to its posterior surface via a short peritoneal fold called the mesovarium.
2. Suspensory ligament of the ovary — extends from the lateral pole of the ovary to the pelvic wall. This ligament contains the ovarian artery, ovarian vein, and lymphatics — it is the neurovascular lifeline of the ovary.
3. Ovarian ligament (utero-ovarian ligament) — a fibrous cord running within the broad ligament from the medial pole of the ovary to the uterus near the uterotubal junction.

25.2.2 Internal Anatomy

Each ovary has two distinct regions:

• Cortex: the outer region, densely packed with ovarian follicles at various stages of development. The cortex is where oocytes are housed and where folliculogenesis occurs.
• Medulla: the inner core, containing loose connective tissue, blood vessels, lymphatics, and nerves.

The ovary is covered by two surface layers: an outer simple cuboidal epithelium (often misleadingly called the germinal epithelium — a historical misnomer, as it does not give rise to germ cells), and beneath it a dense fibrous connective tissue capsule called the tunica albuginea.

25.2.3 Ovarian Follicles — Overview

At birth, each ovary contains approximately 1–2 million primordial follicles, each consisting of a primary oocyte arrested in prophase I of meiosis I, surrounded by a single layer of flattened follicular (granulosa) cells. By puberty, this number declines to about 300,000 due to a continuous process of atresia (follicular degeneration). Over a woman's reproductive lifetime, only approximately 400–500 follicles will complete development and ovulate; the rest become atretic.

25.3 The Uterine (Fallopian) Tubes

The uterine tubes (also called fallopian tubes or oviducts) are paired muscular tubes, approximately 10–12 cm long, extending from the region of each ovary to the superior-lateral region of the uterus. They are not directly attached to the ovaries — instead, their open distal ends hover near the ovarian surface to capture the ovulated secondary oocyte. The tube has four anatomical segments, listed from lateral (near the ovary) to medial (entering the uterus):

1. Infundibulum: the funnel-shaped, flared distal opening. Its margin bears numerous finger-like projections called fimbriae, which sweep over the ovarian surface. At ovulation, fimbriae create currents in the peritoneal fluid that help guide the oocyte into the tube.
2. Ampulla: the longest and widest segment, with a highly folded mucosa. This is the normal site of fertilization — sperm meet the secondary oocyte here, usually within 12–24 hours of ovulation.
3. Isthmus: a narrower, thicker-walled segment that connects the ampulla to the uterus.
4. Intramural (interstitial) portion: the short segment that passes through the uterine wall and opens into the uterine cavity via a tiny opening called the uterotubal junction.

The wall of the uterine tube consists of three layers: an outer serosa, a middle smooth muscle layer (inner circular and outer longitudinal), and an inner mucosa lined by ciliated columnar epithelium interspersed with peg cells (secretory, non-ciliated cells). The ciliary beating creates a slow current toward the uterus, while peristaltic contractions of the smooth muscle also assist in transporting the oocyte (or embryo) toward the uterus.

25.4 The Uterus

25.4.1 Gross Anatomy

The uterus is a hollow, thick-walled, pear-shaped muscular organ located in the pelvic cavity between the bladder (anterior) and the rectum (posterior). It is divided into three anatomical regions:

• Fundus: the rounded, dome-shaped superior portion above the entry points of the uterine tubes.
• Body (corpus): the main, tapering central portion. It is the site of embryo implantation and the chamber where the fetus develops.
• Cervix: the narrow, cylindrical inferior neck that projects into the vagina. The cervix contains the cervical canal, which connects the uterine cavity to the vaginal lumen. The external opening (external os) opens into the vagina; the internal opening (internal os) opens into the uterine cavity.

25.4.2 Uterine Wall — Three Layers

The uterine wall is composed of three histological layers, from outermost to innermost:

1. Perimetrium — the outermost serosal layer. It is the visceral peritoneum that covers the fundus and posterior surface of the body; laterally it becomes the broad ligament.
2. Myometrium — the thick middle layer of smooth muscle. It is the contractile powerhouse of the uterus, responsible for:
   • Expelling menstrual fluid during menstruation.
   • Producing the powerful rhythmic contractions of labor and delivery (parturition).
   • The myometrium hypertrophies dramatically during pregnancy (both hyperplasia and hypertrophy of smooth muscle cells) and is highly responsive to oxytocin and prostaglandins.

1. Endometrium — the innermost mucosal lining. It undergoes cyclic changes driven by ovarian hormones and is structurally divided into two sub-layers:
   • Stratum functionalis (functional layer): the superficial layer that thickens during the proliferative and secretory phases of the uterine cycle in preparation for implantation. If fertilization does not occur, it is shed during menstruation. It contains the spiral (coiled) arteries that constrict prior to menstruation, causing ischemia and tissue necrosis.
   • Stratum basalis (basal layer): the deep, permanent layer adjacent to the myometrium. It is not shed during menstruation and serves as the regenerative source — its stem cells rapidly divide to rebuild the functional layer after each menstrual period.

25.4.3 Cervix and Cervical Mucus

The cervical canal is lined by a mucus-secreting simple columnar epithelium that produces cervical mucus. The consistency of this mucus changes cyclically under hormonal influence:

• Under estrogen dominance (late follicular phase, around ovulation): mucus becomes thin, watery, alkaline, and forms channels that facilitate sperm passage. Cervical mucus at this stage exhibits spinnbarkeit (stretchability) and a ferning pattern when dried on a slide.
• Under progesterone dominance (luteal phase): mucus becomes thick, viscous, and forms a plug that blocks sperm and pathogens.

25.5 The Vagina

The vagina is a fibromuscular tube, approximately 8–10 cm long, extending from the cervix to the external opening (vaginal orifice) at the vestibule of the vulva. It serves as the female copulatory organ, the birth canal during parturition, and the passageway for menstrual fluid. Key anatomical features include:

• Fornices: the recessed spaces surrounding the vaginal projection of the cervix. The posterior fornix is the deepest and is clinically significant as a site for culdocentesis (sampling fluid from the rectouterine pouch / pouch of Douglas).
• Rugae: transverse folds in the vaginal mucosa that allow the vagina to stretch dramatically during intercourse and childbirth.
• Mucosa: lined by nonkeratinized stratified squamous epithelium, which is resistant to friction. The underlying lamina propria is rich in elastic fibers and blood vessels, but the vagina has no glands — vaginal lubrication comes primarily from transudation across the epithelium and secretions from the cervical and vestibular glands.
• Vaginal pH: normally acidic (approximately 3.8–4.5), maintained by Lactobacillus species (part of the normal vaginal microbiota) that metabolize glycogen from shed epithelial cells and produce lactic acid. This acidic environment inhibits pathogen growth and protects against infections.

25.6 External Genitalia (Vulva)

The external female genitalia, collectively called the vulva or pudendum, include:

25.7 Oogenesis

Oogenesis is the process by which diploid oogonia develop into haploid ova (mature eggs). Unlike spermatogenesis, which is continuous from puberty onward, oogenesis is a discontinuous process that begins before birth, pauses, and completes only at fertilization. The timeline is critical:

1. Prenatal period (fetal development): Primordial germ cells migrate to the developing ovaries and differentiate into oogonia (diploid, 2n). Oogonia undergo multiple rounds of mitosis to increase their numbers. By about the fifth month of gestation, the fetal ovary contains approximately 7 million oogonia. These oogonia then enter meiosis I, becoming primary oocytes. The primary oocytes begin prophase I but become arrested in the dictyotene stage (a prolonged diplotene of prophase I) and remain arrested until puberty. By birth, many have degenerated, leaving approximately 1–2 million primary oocytes — all of which a female will ever have.

1. Childhood: Primary oocytes remain arrested in prophase I. Follicular atresia continues; by puberty, only about 300,000 remain.

1. Each menstrual cycle (post-puberty): A cohort of primordial follicles begins to develop. Usually, one dominant follicle completes maturation. Just before ovulation, the primary oocyte within that follicle resumes and completes meiosis I, producing two haploid (1n) cells of unequal size:
   • A large secondary oocyte (1n, 23 chromosomes, each with 2 chromatids) — receives nearly all the cytoplasm.
   • A tiny first polar body (1n, 23 chromosomes, each with 2 chromatids) — receives minimal cytoplasm and typically degenerates.

1. The secondary oocyte immediately begins meiosis II but becomes arrested in metaphase II. It is at this stage — secondary oocyte arrested in metaphase II — that ovulation occurs.

1. Fertilization: If a sperm penetrates the secondary oocyte, meiosis II is completed. The secondary oocyte divides asymmetrically to produce:
   • A mature ovum (1n, 23 chromosomes, each with 1 chromatid).
   • A second polar body (1n, 23 chromosomes, each with 1 chromatid), which degenerates.

If fertilization does not occur, the secondary oocyte degenerates within 24 hours of ovulation without completing meiosis II.

Key comparison — spermatogenesis vs. oogenesis:

• Spermatogenesis: 1 spermatogonium → 4 haploid spermatozoa (symmetric divisions after Meiosis II). Continuous from puberty.
• Oogenesis: 1 oogonium → 1 haploid ovum + 2–3 polar bodies (asymmetric divisions). Arrested at prophase I (prenatal) and metaphase II (at ovulation), completing only at fertilization.

25.8 The Ovarian Cycle

The ovarian cycle is the monthly sequence of events in the ovary involving the maturation of a follicle, release of the secondary oocyte (ovulation), and transformation of the ruptured follicle into an endocrine structure. A typical cycle lasts approximately 28 days, though wide variation is normal (21–35 days). It is divided into three phases:

25.8.1 Follicular Phase (Days 1–14)

The follicular phase spans from the first day of menstruation to ovulation. It is dominated by FSH and, increasingly, rising estrogen levels. The sequence of follicular development proceeds as follows:

1. Primordial follicle activation: FSH recruits a cohort of primordial follicles to begin development. The flattened follicular cells become cuboidal, marking the transition to a primary follicle. The oocyte enlarges and secretes the zona pellucida — a thick glycoprotein coat between the oocyte and granulosa cells that contains species-specific sperm receptors (ZP3).

1. Primary → Secondary follicle: Granulosa cells proliferate from a single layer into multiple layers (now a stratified epithelium). Stromal cells surrounding the follicle differentiate into two layers of theca cells under the influence of LH:
   • Theca interna: a highly vascularized inner layer that expresses LH receptors and produces androgens (androstenedione and testosterone).
   • Theca externa: a fibrous outer capsule.

1. Secondary → Tertiary (antral/Graafian) follicle: The granulosa cells secrete fluid that coalesces into a fluid-filled cavity called the antrum. The follicle is now called an antral or tertiary follicle. The oocyte, surrounded by a cluster of granulosa cells called the cumulus oophorus, is pushed to one side. The innermost layer of granulosa cells immediately surrounding the zona pellucida is called the corona radiata.

1. Two-cell model of estrogen synthesis: Estrogen production in the ovary requires cooperation between theca and granulosa cells — this is the two-cell, two-gonadotropin model:
   • Theca interna cells (stimulated by LH): convert cholesterol → androstenedione and testosterone (androgens) via the enzyme CYP17.
   • Granulosa cells (stimulated by FSH): take up androgens from the theca and convert them to estradiol (the most potent estrogen) via the enzyme aromatase (CYP19). FSH upregulates aromatase expression.
   • The estradiol then diffuses into the circulation to exert systemic effects and also acts locally within the follicle to promote further granulosa proliferation and FSH receptor expression (an autocrine/paracrine positive feedback loop within the follicle).

1. Selection of the dominant follicle: By days 5–7, one follicle becomes dominant — it expresses the most FSH receptors and aromatase, produces the most estrogen, and best survives the declining FSH levels (which fall due to negative feedback from rising estrogen and inhibin). The other recruited follicles undergo atresia (degeneration). The dominant follicle continues to grow to approximately 20–25 mm in diameter by ovulation.

25.8.2 Ovulation (Day 14 in a 28-day cycle)

Ovulation is the rupture of the mature Graafian follicle and release of the secondary oocyte (arrested in metaphase II) into the peritoneal cavity near the fimbriae of the uterine tube. The trigger is a massive surge of LH from the anterior pituitary:

• Sustained high levels of estrogen (from the dominant follicle) exert positive feedback on the hypothalamus and anterior pituitary, triggering the LH surge (with a smaller FSH surge).
• The LH surge causes:
  • Resumption and completion of meiosis I in the primary oocyte → secondary oocyte + first polar body.
  • Weakening and rupture of the follicular wall at the stigma (a protruding avascular spot on the ovarian surface) due to proteolytic enzymes (collagenase) and prostaglandins.
  • Release of the secondary oocyte (surrounded by the corona radiata) into the peritoneal cavity.
  • Transformation of the remaining granulosa and theca cells into the corpus luteum (luteinization).

The fimbriae of the infundibulum sweep the oocyte into the uterine tube. A woman may experience mittelschmerz — a transient lower abdominal pain at the time of ovulation, likely due to peritoneal irritation from follicular fluid or blood.

25.8.3 Luteal Phase (Days 15–28)

The luteal phase spans from ovulation to the onset of menstruation. It is the most constant phase in duration (~14 days) and is dominated by progesterone from the corpus luteum (Latin: "yellow body"):

1. Corpus luteum formation: Under the influence of LH, the ruptured follicle collapses and the remaining granulosa cells and theca interna cells undergo luteinization:
   • Granulosa lutein cells: convert to large luteal cells that produce progesterone and some estrogen.
   • Theca lutein cells: convert to small luteal cells that produce androgens and progesterone.
   • The corpus luteum also secretes inhibin, which suppresses FSH.

1. Progesterone actions during the luteal phase: Progesterone prepares the endometrium for potential implantation — it thickens the functional layer, stimulates endometrial gland secretion (secretory phase of the uterine cycle), and quiets uterine contractions. It also raises basal body temperature by ~0.3–0.5 °C (a clinical indicator used to confirm ovulation).

1. Fate of the corpus luteum — two pathways:

• If fertilization does NOT occur: The corpus luteum has an intrinsic lifespan of approximately 10–12 days. Without sustained LH (which declines due to negative feedback from progesterone), the corpus luteum degenerates into a white scar of fibrous tissue called the corpus albicans. With the loss of the corpus luteum, progesterone and estrogen levels drop sharply. This withdrawal of hormonal support triggers the spiral arteries of the endometrium to constrict, causing ischemia, necrosis, and sloughing of the stratum functionalis — menstruation (days 1–5 of the next cycle). The falling progesterone and estrogen remove negative feedback on the hypothalamus/pituitary, allowing FSH to rise again and initiate the next follicular phase.

• If fertilization DOES occur: The developing embryo (specifically the syncytiotrophoblast) secretes human chorionic gonadotropin (hCG) — an LH analog that "rescues" the corpus luteum. hCG maintains the corpus luteum, which continues to secrete progesterone and estrogen to sustain the endometrium until the placenta takes over this endocrine function at approximately 8–10 weeks of gestation. This is the basis of pregnancy tests, which detect hCG in urine or blood.

25.9 Hormonal Regulation of the Ovarian Cycle

The ovarian cycle is driven by the hypothalamic-pituitary-ovarian (HPO) axis, a classic neuroendocrine feedback loop:

25.9.1 Feedback Mechanisms

• Negative feedback: Moderate levels of estrogen (early–mid follicular phase) + progesterone (luteal phase) + inhibin suppress GnRH, FSH, and LH. This prevents overstimulation and restricts follicular development to the dominant follicle.
• Positive feedback (unique to the female HPO axis): Sustained, high levels of estrogen (from the mature dominant follicle) for approximately 36–50 hours switch the hypothalamic-pituitary response from negative to positive, triggering the massive LH surge that induces ovulation. This positive feedback mechanism is absent in males.

25.9.2 Summary of Hormonal Phases

25.10 Clinical Correlations

25.10.1 Polycystic Ovary Syndrome (PCOS)

PCOS is a common endocrine disorder characterized by hyperandrogenism (excess androgens), ovulatory dysfunction (oligo-ovulation or anovulation), and polycystic ovarian morphology on ultrasound (multiple small antral follicles that fail to mature). The pathophysiology involves insulin resistance driving theca cell androgen overproduction, combined with an altered LH:FSH ratio (elevated LH relative to FSH). The excess androgens are aromatized to estrogen in adipose tissue, producing a state of chronic estrogen exposure without progesterone opposition, which increases endometrial cancer risk.

25.10.2 Endometriosis

Endometriosis is the presence of functional endometrial tissue (glands and stroma) outside the uterine cavity — commonly on the ovaries, pelvic peritoneum, and rectouterine pouch. This ectopic tissue responds to ovarian hormones, proliferating and shedding with each cycle, causing inflammation, pain (dysmenorrhea, dyspareunia), and adhesions. It is a leading cause of infertility due to anatomical distortion and a pro-inflammatory peritoneal environment toxic to sperm and embryos.

25.10.3 Ectopic Pregnancy

An ectopic pregnancy occurs when a fertilized embryo implants outside the uterine cavity, most commonly in the ampulla of the uterine tube (~95% of ectopics). Risk factors include pelvic inflammatory disease (PID), which damages tubal cilia and creates adhesions that trap the embryo. An ectopic pregnancy is a life-threatening emergency — the growing embryo can rupture the tube, causing massive intraperitoneal hemorrhage. Falling hCG levels or an empty uterus on ultrasound with positive hCG are diagnostic clues.

25.10.4 Pelvic Inflammatory Disease (PID)

PID is an ascending infection from the lower genital tract (commonly Chlamydia trachomatis or Neisseria gonorrhoeae) that inflames the uterus, uterine tubes, and ovaries. Tubal inflammation damages the ciliated epithelium and can cause scarring (adhesions/salpingitis), leading to tubal factor infertility and increased ectopic pregnancy risk.

25.10.5 Ovarian Cysts

Functional ovarian cysts are common and usually benign. Follicular cysts form when a follicle fails to rupture at ovulation and continues to enlarge. Corpus luteum cysts form when the corpus luteum fills with fluid or blood instead of regressing. Most resolve spontaneously within a few cycles.

25.10.6 Menopause

Menopause is the permanent cessation of menstrual cycles, diagnosed after 12 consecutive months of amenorrhea, typically occurring around age 51 (range 45–55). It results from depletion of ovarian follicles (the finite ovarian reserve is exhausted). Key hormonal changes:

• Estrogen drops dramatically — the ovaries are no longer producing estradiol. Estrone becomes the dominant estrogen, produced by peripheral aromatization of adrenal androgens in adipose tissue.
• FSH and LH rise markedly due to loss of negative feedback (no estrogen, no inhibin). Elevated FSH is a laboratory hallmark of menopause.
• Symptoms: hot flashes (vasomotor instability), vaginal dryness/atrophy, mood changes, sleep disturbances, and accelerated bone loss leading to osteoporosis risk.
• Hormone replacement therapy (HRT): estrogen (with progesterone in women with an intact uterus to prevent endometrial hyperplasia/cancer) can alleviate vasomotor symptoms and reduce bone loss, though risks (thromboembolism, breast cancer) must be weighed.